Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen cholesterol drug meets goal of third late stage trial
Amgen cholesterol drug meets goal of third late stage trial
Amgen cholesterol drug meets goal of third late stage trial
Submitted by
admin
on January 23, 2014 - 5:53pm
Source:
Yahoo/Reuters
News Tags:
Amgen
evolocumab
PCSK9 inhibitors
Headline:
Amgen cholesterol drug meets goal of third late stage trial
Do Not Allow Advertisers to Use My Personal information
